Predictors of Health Service Utilizations Among Key Population in Washington DC

Launched by US HELPING US, PEOPLE INTO LIVING, INC. · Sep 13, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how the use of PrEP (a medication that helps prevent HIV) affects people’s use of health and social services in Washington, DC. The main goal is to see if people who are using PrEP access more services, like sexual health screenings, mental health support, and other community resources, compared to those who have never used PrEP before. Researchers will follow participants for 12 months to gather this information.

To be eligible for the study, participants must be 18 years or older, live in the Washington, DC area, and be confirmed as HIV-negative. They should also either be new to PrEP or currently using it. Participants can expect to engage with various health services during the study and will be asked to complete some assessments over the year. It's important to note that individuals who are younger than 18, do not speak or read English, or cannot provide consent cannot participate. This study aims to better understand how PrEP users interact with health services, which could help improve support for people at risk of HIV.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age of 18 years or above;
• • confirmed HIV-negative status;
• • residence in the Washington, DC metropolitan area;
• • one of the following PrEP profiles (PrEP naïve \[no history of any PrEP use in the past\] currently on daily oral PrEP or receiving LAI-PrEP).
• Exclusion Criteria:
• • being younger than18 years of age
• • being unable to speak and/or read English
• • a reported residence outside of the defined Washington, DC metropolitan area
• • being unable or unwilling to provide written informed consent
• • being unable to comply with the requirements of the protocol (i.e. persons with mental health conditions, persons who are intoxicated or incoherent for other reasons)
• • evidence of suspected hepatoxicity